Molecular mechanism of anti-cancer activity of phycocyanin in triple-negative breast cancer cells View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2015-10-23

AUTHORS

Mathangi Ravi, Shilpa Tentu, Ganga Baskar, Surabhi Rohan Prasad, Swetha Raghavan, Prajisha Jayaprakash, Jeyaraman Jeyakanthan, Suresh K Rayala, Ganesh Venkatraman

ABSTRACT

BACKGROUND: Triple-negative breast cancers represent an important clinical challenge, as these cancers do not respond to conventional endocrine therapies or other available targeted agents. Phycocyanin (PC), a natural, water soluble and non-toxic molecule is shown to have potent anti-cancer property. METHODS: In this study, we determined the efficacy of PC as an anti-neoplastic agent in vitro on a series of breast cancer cell lines. We studied effects of PC in inducing DNA damage and apoptosis through western blot and qPCR. Also, anti-metastatic and anti-angiogenic properties were studied by classic wound healing and vasculogenic mimicry assays. RESULTS: We found that triple negative MDA-MB-231 cells were most sensitive to PC (IC50 : 5.98 ± 0.95 μM) as compared to other cells. They also showed decreased cell proliferation and reduced colony formation ability upon treatment with PC. Profile of Cell cycle analysis showed that PC caused G1 arrest which could be attributed to decreased mRNA levels of Cyclin E and CDK-2 and increased p21 levels. Mechanistic studies revealed that PC induced apoptosis as evident by increase in percentage of annexin positive cells, increase in γ-H2AX levels, and by changing the Bcl-2/Bax ratio followed by release of cytochrome C and increased Caspase 9 levels. MDA MB 231 cells treated with PC resulted in decreased cell migration and increased cell adhesive property and also showed anti-angiogenic effects. We also observed that PC suppressed cyclooxygenase-2 (COX-2) expression and prostaglandin E(2) production. All these biological effects of phycocyanin on MDA MB 231 cells could be attributed to decreased MAPK signaling pathway. We also observed that PC is non-toxic to non-malignant cells, platelets and RBC's. CONCLUSION: Taken together, these findings demonstrate, for the first time, that PC may be a promising anti-neoplastic agent for treatment of triple negative breast cancers. More... »

PAGES

768

References to SciGraph publications

  • 2004-04-12. Mitogen-activated protein kinases in apoptosis regulation in ONCOGENE
  • 2014-12-05. Association of BRCA1/2defects with genomic scores predictive of DNA damage repair deficiency among breast cancer subtypes in BREAST CANCER RESEARCH
  • 2013-04-08. A randomised controlled phase II trial of pre-operative celecoxib treatment reveals anti-tumour transcriptional response in primary breast cancer in BREAST CANCER RESEARCH
  • 2014-02-14. Induction of apoptosis through oxidative stress-related pathways in MCF-7, human breast cancer cells, by ethyl acetate extract of Dillenia suffruticosa in BMC COMPLEMENTARY MEDICINE AND THERAPIES
  • 2013-11-14. The natural compound magnolol inhibits invasion and exhibits potential in human breast cancer therapy in SCIENTIFIC REPORTS
  • 2007-05. DNA-damage response network at the crossroads of cell-cycle checkpoints, cellular senescence and apoptosis in JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B
  • 2006-12-11. A novel role for cyclooxygenase-2 in regulating vascular channel formation by human breast cancer cells in BREAST CANCER RESEARCH
  • 2007-05-14. MAP kinase signalling pathways in cancer in ONCOGENE
  • 2011-10-12. Chemoprevention of DMH-induced rat colon carcinoma initiation by combination administration of piroxicam and C-phycocyanin in MOLECULAR AND CELLULAR BIOCHEMISTRY
  • 2009-10-01. Suppression of growth, migration and invasion of highly-metastatic human breast cancer cells by berbamine and its molecular mechanisms of action in MOLECULAR CANCER
  • 2014-08-31. Smurf2 E3 ubiquitin ligase modulates proliferation and invasiveness of breast cancer cells in a CNKSR2 dependent manner in CELL DIVISION
  • 2008-06-12. Neutral red uptake assay for the estimation of cell viability/cytotoxicity in NATURE PROTOCOLS
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1186/s12885-015-1784-x

    DOI

    http://dx.doi.org/10.1186/s12885-015-1784-x

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1011241259

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/26499490


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Oncology and Carcinogenesis", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Antineoplastic Agents", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Apoptosis", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Blotting, Western", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Caspase 9", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Cell Cycle", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Cell Line, Tumor", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Cell Movement", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Cell Proliferation", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Cyclooxygenase 2", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "DNA Damage", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Female", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Flow Cytometry", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Humans", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Molecular Targeted Therapy", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Phycocyanin", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Signal Transduction", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Triple Negative Breast Neoplasms", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "Department of Human Genetics, Sri Ramachandra University, Chennai, 600116 India", 
              "id": "http://www.grid.ac/institutes/grid.412734.7", 
              "name": [
                "Department of Human Genetics, Sri Ramachandra University, Chennai, 600116 India"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Ravi", 
            "givenName": "Mathangi", 
            "id": "sg:person.01131161701.74", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01131161701.74"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Biotechnology, Indian Institute of Technology Madras (IITM), Chennai, 600036 India", 
              "id": "http://www.grid.ac/institutes/grid.417969.4", 
              "name": [
                "Department of Biotechnology, Indian Institute of Technology Madras (IITM), Chennai, 600036 India"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Tentu", 
            "givenName": "Shilpa", 
            "id": "sg:person.01177275101.74", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01177275101.74"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Human Genetics, Sri Ramachandra University, Chennai, 600116 India", 
              "id": "http://www.grid.ac/institutes/grid.412734.7", 
              "name": [
                "Department of Human Genetics, Sri Ramachandra University, Chennai, 600116 India"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Baskar", 
            "givenName": "Ganga", 
            "id": "sg:person.01060064403.13", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01060064403.13"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Biotechnology, Indian Institute of Technology Madras (IITM), Chennai, 600036 India", 
              "id": "http://www.grid.ac/institutes/grid.417969.4", 
              "name": [
                "Department of Biotechnology, Indian Institute of Technology Madras (IITM), Chennai, 600036 India"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Prasad", 
            "givenName": "Surabhi Rohan", 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Biotechnology, Indian Institute of Technology Madras (IITM), Chennai, 600036 India", 
              "id": "http://www.grid.ac/institutes/grid.417969.4", 
              "name": [
                "Department of Biotechnology, Indian Institute of Technology Madras (IITM), Chennai, 600036 India"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Raghavan", 
            "givenName": "Swetha", 
            "id": "sg:person.01361636701.92", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01361636701.92"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Bioinformatics, Alagappa University, Karaikudi, India", 
              "id": "http://www.grid.ac/institutes/grid.411312.4", 
              "name": [
                "Department of Bioinformatics, Alagappa University, Karaikudi, India"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Jayaprakash", 
            "givenName": "Prajisha", 
            "id": "sg:person.0636232601.20", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0636232601.20"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Bioinformatics, Alagappa University, Karaikudi, India", 
              "id": "http://www.grid.ac/institutes/grid.411312.4", 
              "name": [
                "Department of Bioinformatics, Alagappa University, Karaikudi, India"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Jeyakanthan", 
            "givenName": "Jeyaraman", 
            "id": "sg:person.0751171521.56", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0751171521.56"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Biotechnology, Indian Institute of Technology Madras (IITM), Chennai, 600036 India", 
              "id": "http://www.grid.ac/institutes/grid.417969.4", 
              "name": [
                "Department of Biotechnology, Indian Institute of Technology Madras (IITM), Chennai, 600036 India"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Rayala", 
            "givenName": "Suresh K", 
            "id": "sg:person.0607213340.77", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0607213340.77"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Human Genetics, Sri Ramachandra University, Chennai, 600116 India", 
              "id": "http://www.grid.ac/institutes/grid.412734.7", 
              "name": [
                "Department of Human Genetics, Sri Ramachandra University, Chennai, 600116 India"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Venkatraman", 
            "givenName": "Ganesh", 
            "id": "sg:person.01277571576.39", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01277571576.39"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1186/s13058-014-0475-x", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1049061810", 
              "https://doi.org/10.1186/s13058-014-0475-x"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s11010-011-1106-9", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1028527144", 
              "https://doi.org/10.1007/s11010-011-1106-9"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1186/bcr3409", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1018407370", 
              "https://doi.org/10.1186/bcr3409"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1186/1747-1028-9-2", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1007400687", 
              "https://doi.org/10.1186/1747-1028-9-2"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1186/1476-4598-8-81", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1033538052", 
              "https://doi.org/10.1186/1476-4598-8-81"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nprot.2008.75", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1028002814", 
              "https://doi.org/10.1038/nprot.2008.75"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/srep03098", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1047627599", 
              "https://doi.org/10.1038/srep03098"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1631/jzus.2007.b0377", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1018854889", 
              "https://doi.org/10.1631/jzus.2007.b0377"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1186/bcr1626", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1014737070", 
              "https://doi.org/10.1186/bcr1626"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.onc.1210421", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1002864504", 
              "https://doi.org/10.1038/sj.onc.1210421"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.onc.1207556", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1006947464", 
              "https://doi.org/10.1038/sj.onc.1207556"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1186/1472-6882-14-55", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1036623059", 
              "https://doi.org/10.1186/1472-6882-14-55"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "2015-10-23", 
        "datePublishedReg": "2015-10-23", 
        "description": "BACKGROUND: Triple-negative breast cancers represent an important clinical challenge, as these cancers do not respond to conventional endocrine therapies or other available targeted agents. Phycocyanin (PC), a natural, water soluble and non-toxic molecule is shown to have potent anti-cancer property.\nMETHODS: In this study, we determined the efficacy of PC as an anti-neoplastic agent in vitro on a series of breast cancer cell lines. We studied effects of PC in inducing DNA damage and apoptosis through western blot and qPCR. Also, anti-metastatic and anti-angiogenic properties were studied by classic wound healing and vasculogenic mimicry assays.\nRESULTS: We found that triple negative MDA-MB-231 cells were most sensitive to PC (IC50 : 5.98 \u00b1 0.95 \u03bcM) as compared to other cells. They also showed decreased cell proliferation and reduced colony formation ability upon treatment with PC. Profile of Cell cycle analysis showed that PC caused G1 arrest which could be attributed to decreased mRNA levels of Cyclin E and CDK-2 and increased p21 levels. Mechanistic studies revealed that PC induced apoptosis as evident by increase in percentage of annexin positive cells, increase in \u03b3-H2AX levels, and by changing the Bcl-2/Bax ratio followed by release of cytochrome C and increased Caspase 9 levels. MDA MB 231 cells treated with PC resulted in decreased cell migration and increased cell adhesive property and also showed anti-angiogenic effects. We also observed that PC suppressed cyclooxygenase-2 (COX-2) expression and prostaglandin E(2) production. All these biological effects of phycocyanin on MDA MB 231 cells could be attributed to decreased MAPK signaling pathway. We also observed that PC is non-toxic to non-malignant cells, platelets and RBC's.\nCONCLUSION: Taken together, these findings demonstrate, for the first time, that PC may be a promising anti-neoplastic agent for treatment of triple negative breast cancers.", 
        "genre": "article", 
        "id": "sg:pub.10.1186/s12885-015-1784-x", 
        "inLanguage": "en", 
        "isAccessibleForFree": true, 
        "isPartOf": [
          {
            "id": "sg:journal.1024632", 
            "issn": [
              "1471-2407"
            ], 
            "name": "BMC Cancer", 
            "publisher": "Springer Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "1", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "15"
          }
        ], 
        "keywords": [
          "MDA-MB-231 cells", 
          "triple-negative breast cancer", 
          "MB-231 cells", 
          "anti-neoplastic agents", 
          "breast cancer", 
          "triple-negative MDA-MB-231 cells", 
          "negative MDA-MB-231 cells", 
          "promising anti-neoplastic agent", 
          "conventional endocrine therapy", 
          "potent anti-cancer properties", 
          "triple-negative breast cancer cells", 
          "important clinical challenge", 
          "negative breast cancer", 
          "cyclooxygenase-2 expression", 
          "breast cancer cell lines", 
          "Bcl-2/Bax ratio", 
          "anti-angiogenic effects", 
          "annexin positive cells", 
          "anti-angiogenic properties", 
          "caspase-9 levels", 
          "breast cancer cells", 
          "effects of phycocyanin", 
          "colony formation ability", 
          "non-malignant cells", 
          "anti-cancer properties", 
          "endocrine therapy", 
          "cancer cell lines", 
          "anti-cancer activity", 
          "cell cycle analysis", 
          "clinical challenge", 
          "positive cells", 
          "vasculogenic mimicry", 
          "Western blot", 
          "Bax ratio", 
          "cancer cells", 
          "cancer", 
          "p21 levels", 
          "wound healing", 
          "mRNA levels", 
          "cell proliferation", 
          "H2AX levels", 
          "G1 arrest", 
          "cyclin E", 
          "cell lines", 
          "CDK-2", 
          "cell migration", 
          "biological effects", 
          "molecular mechanisms", 
          "non-toxic molecules", 
          "cells", 
          "treatment", 
          "DNA damage", 
          "apoptosis", 
          "formation ability", 
          "cycle analysis", 
          "agents", 
          "levels", 
          "therapy", 
          "prostaglandins", 
          "efficacy", 
          "healing", 
          "mechanistic studies", 
          "blot", 
          "platelets", 
          "arrest", 
          "effect", 
          "study", 
          "proliferation", 
          "RBCs", 
          "MAPK", 
          "qPCR", 
          "expression", 
          "findings", 
          "pathway", 
          "percentage", 
          "release", 
          "damage", 
          "cytochrome c", 
          "cell adhesive properties", 
          "activity", 
          "mimicry", 
          "increase", 
          "first time", 
          "profile", 
          "migration", 
          "mechanism", 
          "ability", 
          "adhesive properties", 
          "lines", 
          "ratio", 
          "time", 
          "analysis", 
          "production", 
          "series", 
          "challenges", 
          "molecules", 
          "phycocyanin", 
          "properties", 
          "water", 
          "efficacy of PC", 
          "classic wound healing"
        ], 
        "name": "Molecular mechanism of anti-cancer activity of phycocyanin in triple-negative breast cancer cells", 
        "pagination": "768", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1011241259"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1186/s12885-015-1784-x"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "26499490"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1186/s12885-015-1784-x", 
          "https://app.dimensions.ai/details/publication/pub.1011241259"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2021-11-01T18:25", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20211101/entities/gbq_results/article/article_680.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1186/s12885-015-1784-x"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s12885-015-1784-x'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s12885-015-1784-x'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s12885-015-1784-x'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s12885-015-1784-x'


     

    This table displays all metadata directly associated to this object as RDF triples.

    339 TRIPLES      22 PREDICATES      156 URIs      136 LITERALS      24 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1186/s12885-015-1784-x schema:about N1a261a982a824671a6a841aa807dc461
    2 N1c3d65325e2d4726b08ef48b5361d100
    3 N2aa0eee9e8a64fc7b555f95363ace6e1
    4 N42382658120645f2885630977156bde9
    5 N4e7415cd208b4d3995f3628694730a35
    6 N5e67626b5cce4db693d99be78fb9e054
    7 N68fe92b036674dfcb3b411dfd3e40ec1
    8 N7792ef9dc47e4d9e8cbb7ee9891872a1
    9 N839390c828924a2b9427260a55c00bd8
    10 N8f144a2d9cf3427db06623507301c53a
    11 Nac50a49e66a6435f8a842b706c35a9f8
    12 Nd549fe4da6dd4ce2bf16d9471633b5ba
    13 Nd75aca38e6ed496e94579b6449c75747
    14 Nd89bd0b16e014c32bbb9383b29303a2d
    15 Ndb6603dbaeed4ae08ffc134f40ce9607
    16 Ne85dc7e43933484f9d7965652679c7ba
    17 Neac1c19c18ed4ec9b15f2f258211cce2
    18 anzsrc-for:11
    19 anzsrc-for:1112
    20 schema:author Nffc48498b92b40b88b7518ad34b8c01c
    21 schema:citation sg:pub.10.1007/s11010-011-1106-9
    22 sg:pub.10.1038/nprot.2008.75
    23 sg:pub.10.1038/sj.onc.1207556
    24 sg:pub.10.1038/sj.onc.1210421
    25 sg:pub.10.1038/srep03098
    26 sg:pub.10.1186/1472-6882-14-55
    27 sg:pub.10.1186/1476-4598-8-81
    28 sg:pub.10.1186/1747-1028-9-2
    29 sg:pub.10.1186/bcr1626
    30 sg:pub.10.1186/bcr3409
    31 sg:pub.10.1186/s13058-014-0475-x
    32 sg:pub.10.1631/jzus.2007.b0377
    33 schema:datePublished 2015-10-23
    34 schema:datePublishedReg 2015-10-23
    35 schema:description BACKGROUND: Triple-negative breast cancers represent an important clinical challenge, as these cancers do not respond to conventional endocrine therapies or other available targeted agents. Phycocyanin (PC), a natural, water soluble and non-toxic molecule is shown to have potent anti-cancer property. METHODS: In this study, we determined the efficacy of PC as an anti-neoplastic agent in vitro on a series of breast cancer cell lines. We studied effects of PC in inducing DNA damage and apoptosis through western blot and qPCR. Also, anti-metastatic and anti-angiogenic properties were studied by classic wound healing and vasculogenic mimicry assays. RESULTS: We found that triple negative MDA-MB-231 cells were most sensitive to PC (IC50 : 5.98 ± 0.95 μM) as compared to other cells. They also showed decreased cell proliferation and reduced colony formation ability upon treatment with PC. Profile of Cell cycle analysis showed that PC caused G1 arrest which could be attributed to decreased mRNA levels of Cyclin E and CDK-2 and increased p21 levels. Mechanistic studies revealed that PC induced apoptosis as evident by increase in percentage of annexin positive cells, increase in γ-H2AX levels, and by changing the Bcl-2/Bax ratio followed by release of cytochrome C and increased Caspase 9 levels. MDA MB 231 cells treated with PC resulted in decreased cell migration and increased cell adhesive property and also showed anti-angiogenic effects. We also observed that PC suppressed cyclooxygenase-2 (COX-2) expression and prostaglandin E(2) production. All these biological effects of phycocyanin on MDA MB 231 cells could be attributed to decreased MAPK signaling pathway. We also observed that PC is non-toxic to non-malignant cells, platelets and RBC's. CONCLUSION: Taken together, these findings demonstrate, for the first time, that PC may be a promising anti-neoplastic agent for treatment of triple negative breast cancers.
    36 schema:genre article
    37 schema:inLanguage en
    38 schema:isAccessibleForFree true
    39 schema:isPartOf N10f919cc86194d5ca9d83bd61eb31c8a
    40 Ne7cabd1a9ae445f091a0fb4246f976bf
    41 sg:journal.1024632
    42 schema:keywords Bax ratio
    43 Bcl-2/Bax ratio
    44 CDK-2
    45 DNA damage
    46 G1 arrest
    47 H2AX levels
    48 MAPK
    49 MB-231 cells
    50 MDA-MB-231 cells
    51 RBCs
    52 Western blot
    53 ability
    54 activity
    55 adhesive properties
    56 agents
    57 analysis
    58 annexin positive cells
    59 anti-angiogenic effects
    60 anti-angiogenic properties
    61 anti-cancer activity
    62 anti-cancer properties
    63 anti-neoplastic agents
    64 apoptosis
    65 arrest
    66 biological effects
    67 blot
    68 breast cancer
    69 breast cancer cell lines
    70 breast cancer cells
    71 cancer
    72 cancer cell lines
    73 cancer cells
    74 caspase-9 levels
    75 cell adhesive properties
    76 cell cycle analysis
    77 cell lines
    78 cell migration
    79 cell proliferation
    80 cells
    81 challenges
    82 classic wound healing
    83 clinical challenge
    84 colony formation ability
    85 conventional endocrine therapy
    86 cycle analysis
    87 cyclin E
    88 cyclooxygenase-2 expression
    89 cytochrome c
    90 damage
    91 effect
    92 effects of phycocyanin
    93 efficacy
    94 efficacy of PC
    95 endocrine therapy
    96 expression
    97 findings
    98 first time
    99 formation ability
    100 healing
    101 important clinical challenge
    102 increase
    103 levels
    104 lines
    105 mRNA levels
    106 mechanism
    107 mechanistic studies
    108 migration
    109 mimicry
    110 molecular mechanisms
    111 molecules
    112 negative MDA-MB-231 cells
    113 negative breast cancer
    114 non-malignant cells
    115 non-toxic molecules
    116 p21 levels
    117 pathway
    118 percentage
    119 phycocyanin
    120 platelets
    121 positive cells
    122 potent anti-cancer properties
    123 production
    124 profile
    125 proliferation
    126 promising anti-neoplastic agent
    127 properties
    128 prostaglandins
    129 qPCR
    130 ratio
    131 release
    132 series
    133 study
    134 therapy
    135 time
    136 treatment
    137 triple-negative MDA-MB-231 cells
    138 triple-negative breast cancer
    139 triple-negative breast cancer cells
    140 vasculogenic mimicry
    141 water
    142 wound healing
    143 schema:name Molecular mechanism of anti-cancer activity of phycocyanin in triple-negative breast cancer cells
    144 schema:pagination 768
    145 schema:productId N525c030d59424488abf17574e63e782c
    146 N9a1ebf57a1b94e80be9a815f0715eebf
    147 Nef434dc66fad4e549e7199d0d60a1746
    148 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011241259
    149 https://doi.org/10.1186/s12885-015-1784-x
    150 schema:sdDatePublished 2021-11-01T18:25
    151 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    152 schema:sdPublisher N3f82caa5da1f4d7596766f5a170289df
    153 schema:url https://doi.org/10.1186/s12885-015-1784-x
    154 sgo:license sg:explorer/license/
    155 sgo:sdDataset articles
    156 rdf:type schema:ScholarlyArticle
    157 N10f919cc86194d5ca9d83bd61eb31c8a schema:issueNumber 1
    158 rdf:type schema:PublicationIssue
    159 N1a261a982a824671a6a841aa807dc461 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    160 schema:name Cell Proliferation
    161 rdf:type schema:DefinedTerm
    162 N1c3d65325e2d4726b08ef48b5361d100 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    163 schema:name Humans
    164 rdf:type schema:DefinedTerm
    165 N240a117ed121440c9017bd76cd0a62e8 schema:affiliation grid-institutes:grid.417969.4
    166 schema:familyName Prasad
    167 schema:givenName Surabhi Rohan
    168 rdf:type schema:Person
    169 N2aa0eee9e8a64fc7b555f95363ace6e1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    170 schema:name Flow Cytometry
    171 rdf:type schema:DefinedTerm
    172 N3f82caa5da1f4d7596766f5a170289df schema:name Springer Nature - SN SciGraph project
    173 rdf:type schema:Organization
    174 N409a72b51bb2428d8fe97a2a63fe5d16 rdf:first sg:person.0607213340.77
    175 rdf:rest N4fc37267aadf4a8187ba009c25ac9b09
    176 N42382658120645f2885630977156bde9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    177 schema:name Antineoplastic Agents
    178 rdf:type schema:DefinedTerm
    179 N4e7415cd208b4d3995f3628694730a35 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    180 schema:name Blotting, Western
    181 rdf:type schema:DefinedTerm
    182 N4fc37267aadf4a8187ba009c25ac9b09 rdf:first sg:person.01277571576.39
    183 rdf:rest rdf:nil
    184 N525c030d59424488abf17574e63e782c schema:name dimensions_id
    185 schema:value pub.1011241259
    186 rdf:type schema:PropertyValue
    187 N5e67626b5cce4db693d99be78fb9e054 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    188 schema:name Signal Transduction
    189 rdf:type schema:DefinedTerm
    190 N68fe92b036674dfcb3b411dfd3e40ec1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    191 schema:name Cell Movement
    192 rdf:type schema:DefinedTerm
    193 N7792ef9dc47e4d9e8cbb7ee9891872a1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    194 schema:name Cyclooxygenase 2
    195 rdf:type schema:DefinedTerm
    196 N839390c828924a2b9427260a55c00bd8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    197 schema:name Phycocyanin
    198 rdf:type schema:DefinedTerm
    199 N8f144a2d9cf3427db06623507301c53a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    200 schema:name Triple Negative Breast Neoplasms
    201 rdf:type schema:DefinedTerm
    202 N9a1ebf57a1b94e80be9a815f0715eebf schema:name pubmed_id
    203 schema:value 26499490
    204 rdf:type schema:PropertyValue
    205 Nac50a49e66a6435f8a842b706c35a9f8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    206 schema:name Female
    207 rdf:type schema:DefinedTerm
    208 Nc5472c71e99f4c829fe0d72b8705cb22 rdf:first sg:person.0751171521.56
    209 rdf:rest N409a72b51bb2428d8fe97a2a63fe5d16
    210 Nc6b2b5900dbd4090a5e02c674b74a84d rdf:first sg:person.0636232601.20
    211 rdf:rest Nc5472c71e99f4c829fe0d72b8705cb22
    212 Nd549fe4da6dd4ce2bf16d9471633b5ba schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    213 schema:name DNA Damage
    214 rdf:type schema:DefinedTerm
    215 Nd75aca38e6ed496e94579b6449c75747 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    216 schema:name Cell Cycle
    217 rdf:type schema:DefinedTerm
    218 Nd89bd0b16e014c32bbb9383b29303a2d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    219 schema:name Cell Line, Tumor
    220 rdf:type schema:DefinedTerm
    221 Ndb6603dbaeed4ae08ffc134f40ce9607 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    222 schema:name Apoptosis
    223 rdf:type schema:DefinedTerm
    224 Ne7cabd1a9ae445f091a0fb4246f976bf schema:volumeNumber 15
    225 rdf:type schema:PublicationVolume
    226 Ne85d1db657094bb0a0a5b57bd241f09f rdf:first N240a117ed121440c9017bd76cd0a62e8
    227 rdf:rest Nf84060728b03485e8cb62d1c18c27d48
    228 Ne85dc7e43933484f9d7965652679c7ba schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    229 schema:name Molecular Targeted Therapy
    230 rdf:type schema:DefinedTerm
    231 Nea267ebfe648497abcf074b2fd5d802b rdf:first sg:person.01177275101.74
    232 rdf:rest Nfb8f5d28398645f9878da7b650c4f48c
    233 Neac1c19c18ed4ec9b15f2f258211cce2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    234 schema:name Caspase 9
    235 rdf:type schema:DefinedTerm
    236 Nef434dc66fad4e549e7199d0d60a1746 schema:name doi
    237 schema:value 10.1186/s12885-015-1784-x
    238 rdf:type schema:PropertyValue
    239 Nf84060728b03485e8cb62d1c18c27d48 rdf:first sg:person.01361636701.92
    240 rdf:rest Nc6b2b5900dbd4090a5e02c674b74a84d
    241 Nfb8f5d28398645f9878da7b650c4f48c rdf:first sg:person.01060064403.13
    242 rdf:rest Ne85d1db657094bb0a0a5b57bd241f09f
    243 Nffc48498b92b40b88b7518ad34b8c01c rdf:first sg:person.01131161701.74
    244 rdf:rest Nea267ebfe648497abcf074b2fd5d802b
    245 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    246 schema:name Medical and Health Sciences
    247 rdf:type schema:DefinedTerm
    248 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
    249 schema:name Oncology and Carcinogenesis
    250 rdf:type schema:DefinedTerm
    251 sg:journal.1024632 schema:issn 1471-2407
    252 schema:name BMC Cancer
    253 schema:publisher Springer Nature
    254 rdf:type schema:Periodical
    255 sg:person.01060064403.13 schema:affiliation grid-institutes:grid.412734.7
    256 schema:familyName Baskar
    257 schema:givenName Ganga
    258 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01060064403.13
    259 rdf:type schema:Person
    260 sg:person.01131161701.74 schema:affiliation grid-institutes:grid.412734.7
    261 schema:familyName Ravi
    262 schema:givenName Mathangi
    263 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01131161701.74
    264 rdf:type schema:Person
    265 sg:person.01177275101.74 schema:affiliation grid-institutes:grid.417969.4
    266 schema:familyName Tentu
    267 schema:givenName Shilpa
    268 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01177275101.74
    269 rdf:type schema:Person
    270 sg:person.01277571576.39 schema:affiliation grid-institutes:grid.412734.7
    271 schema:familyName Venkatraman
    272 schema:givenName Ganesh
    273 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01277571576.39
    274 rdf:type schema:Person
    275 sg:person.01361636701.92 schema:affiliation grid-institutes:grid.417969.4
    276 schema:familyName Raghavan
    277 schema:givenName Swetha
    278 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01361636701.92
    279 rdf:type schema:Person
    280 sg:person.0607213340.77 schema:affiliation grid-institutes:grid.417969.4
    281 schema:familyName Rayala
    282 schema:givenName Suresh K
    283 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0607213340.77
    284 rdf:type schema:Person
    285 sg:person.0636232601.20 schema:affiliation grid-institutes:grid.411312.4
    286 schema:familyName Jayaprakash
    287 schema:givenName Prajisha
    288 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0636232601.20
    289 rdf:type schema:Person
    290 sg:person.0751171521.56 schema:affiliation grid-institutes:grid.411312.4
    291 schema:familyName Jeyakanthan
    292 schema:givenName Jeyaraman
    293 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0751171521.56
    294 rdf:type schema:Person
    295 sg:pub.10.1007/s11010-011-1106-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028527144
    296 https://doi.org/10.1007/s11010-011-1106-9
    297 rdf:type schema:CreativeWork
    298 sg:pub.10.1038/nprot.2008.75 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028002814
    299 https://doi.org/10.1038/nprot.2008.75
    300 rdf:type schema:CreativeWork
    301 sg:pub.10.1038/sj.onc.1207556 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006947464
    302 https://doi.org/10.1038/sj.onc.1207556
    303 rdf:type schema:CreativeWork
    304 sg:pub.10.1038/sj.onc.1210421 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002864504
    305 https://doi.org/10.1038/sj.onc.1210421
    306 rdf:type schema:CreativeWork
    307 sg:pub.10.1038/srep03098 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047627599
    308 https://doi.org/10.1038/srep03098
    309 rdf:type schema:CreativeWork
    310 sg:pub.10.1186/1472-6882-14-55 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036623059
    311 https://doi.org/10.1186/1472-6882-14-55
    312 rdf:type schema:CreativeWork
    313 sg:pub.10.1186/1476-4598-8-81 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033538052
    314 https://doi.org/10.1186/1476-4598-8-81
    315 rdf:type schema:CreativeWork
    316 sg:pub.10.1186/1747-1028-9-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007400687
    317 https://doi.org/10.1186/1747-1028-9-2
    318 rdf:type schema:CreativeWork
    319 sg:pub.10.1186/bcr1626 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014737070
    320 https://doi.org/10.1186/bcr1626
    321 rdf:type schema:CreativeWork
    322 sg:pub.10.1186/bcr3409 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018407370
    323 https://doi.org/10.1186/bcr3409
    324 rdf:type schema:CreativeWork
    325 sg:pub.10.1186/s13058-014-0475-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1049061810
    326 https://doi.org/10.1186/s13058-014-0475-x
    327 rdf:type schema:CreativeWork
    328 sg:pub.10.1631/jzus.2007.b0377 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018854889
    329 https://doi.org/10.1631/jzus.2007.b0377
    330 rdf:type schema:CreativeWork
    331 grid-institutes:grid.411312.4 schema:alternateName Department of Bioinformatics, Alagappa University, Karaikudi, India
    332 schema:name Department of Bioinformatics, Alagappa University, Karaikudi, India
    333 rdf:type schema:Organization
    334 grid-institutes:grid.412734.7 schema:alternateName Department of Human Genetics, Sri Ramachandra University, Chennai, 600116 India
    335 schema:name Department of Human Genetics, Sri Ramachandra University, Chennai, 600116 India
    336 rdf:type schema:Organization
    337 grid-institutes:grid.417969.4 schema:alternateName Department of Biotechnology, Indian Institute of Technology Madras (IITM), Chennai, 600036 India
    338 schema:name Department of Biotechnology, Indian Institute of Technology Madras (IITM), Chennai, 600036 India
    339 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...